Evidence map›Paper›PMID 41978607›Full record

ArticleCureus2026

Cutaneous Rosai-Dorfman Disease Misdiagnosed as Granulomatous Dermatitis: A Diagnostic Pitfall.

Sri Naidnur, Jamie Hedrick, Smaran Marupudi, Kara Asbury, Kelly Maedo, Bryan Gammon, Rick Lin

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sri NaidnurDermatology, Oasis Dermatology Group, McAllen, USA.
Jamie HedrickDermatology, Oasis Dermatology Group, McAllen, USA.
Smaran MarupudiDermatology, University of Texas Rio Grande Valley School of Medicine, McAllen, USA.
Kara AsburyDermatology, Oasis Dermatology Group, McAllen, USA.
Kelly MaedoDermatology, HCA Healthcare Corpus Christi Medical Center-Bay Area Program, McAllen, USA.
Bryan GammonDermatopathology, Sagis Diagnostics, Houston, USA.
Rick LinDermatology, HCA Healthcare Corpus Christi Medical Center-Bay Area Program, McAllen, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous Rosai-Dorfman disease (CRDD) is an uncommon non-Langerhans cell histiocytosis that may occur without systemic involvement and lacks specific clinical features. We report a 17-year-old female with a slowly enlarging chest lesion initially diagnosed as granulomatous dermatitis on a 4-mm punch biopsy. The lesion was treated as an inflammatory process without improvement. Complete excision revealed a multinodular dermal and subcutaneous infiltrate of large histiocytes demonstrating emperipolesis, confirming CRDD. Systemic evaluation was negative. The initial limited biopsy did not capture defining features, delaying diagnosis. Persistent nodular lesions that fail to respond to therapy should prompt reconsideration and more representative tissue sampling. We have also tabulated selected reported cases, which further demonstrate that CRDD is frequently misdiagnosed in routine clinical practice due to nonspecific morphology and limited biopsy sampling.

Indexed as

cd163cd68clinicopathologic correlationcrddcutaneous rosai-dorfman diseasediagnostic pitfallemperipolesisgranulomatous dermatitisnon-langerhans cell histiocytosiss100

Identifiers

PMID41978607
PMCPMC13070514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.